JOHNPHARMA

Johnson Pharmacare Ltd.

0.40+0.0 (+2.56%)
23 Oct, 3:30 PM

Annual Reports and Financial Documents

Johnson Pharmacare Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Johnson Pharmacare Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Closure of Trading Window26 Sept 2026
    Closure of Trading Window
    Pursuant to PIT (Regulation), 2015 the Trading window shall remain closed from 01st October, 2026 till 48 hours after the declaration of unaudited financial result for the quarter and Half ....
  2. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Pursuant to regulation 47 of LODR, 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June, 2026.
  3. Reg. 32 (1), (3) - Statement of Deviation & Variation13 Aug 2026
    Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30Th, 2026.
    Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015
  4. Outcome of Board Meeting13 Aug 2026
    Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday, 13Th August, 2026 At Pursuant To Regulation 30 Of
    UN-AUDITED FINANCIAL RESULTS The Board of Director have considered and approved the Un-Audited Financial Results along with Limited Review Report thereon for quarter ended on June 30th, ....
  5. Change in Registered Office Address11 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Registered Office Address
    The Exchange and Investors are hereby informed that boards of directors of the company had accorded thier approval for shifting of Registered Office of the Company from Existing Address ....
  6. Board Meeting8 Aug 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June, 2026.
    Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve To consider and approve ....
  7. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended on 30th June 2026.
  8. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  9. Resignation of Company Secretary / Compliance Officer12 Jun 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 there is change.
  10. General1 Jun 2026
    Outcome Of Meeting Of Board Of Directors Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The
    meeting of board of director to considered and approved the following 1.audited financial results 2. Statement of deviation or variation 3. take note on resignation of Rajendra prasad (Non- ....
  11. Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual secretarial compliance report for the F.Y 31ST MARCH 2026
  12. Newspaper Publication28 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of Extract of Newspaper Publication of Audited (Standalone) Financial Results for the quarter and year ended on 31st March 2026
  13. Outcome of Board Meeting27 May 2026
    Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The
    Pursuant to the provisions of Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting ....
  14. Board Meeting22 May 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Audited Financial Results For The Quarter & Year Ended On 31St March, 2026.
    Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To consider and approve ....
  15. Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B29 May 2026
    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
    <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
  16. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A30 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  17. Resignation of Director17 Apr 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015
  18. Change in Management17 Apr 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment of mr. Dheeraj ....
  19. Outcome without intimation17 Apr 2026
    Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI
    1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The Board has appointed ....
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026

Frequently Asked Questions

Where can I download the annual report of Johnson Pharmacare Ltd.?
Annual reports of Johnson Pharmacare Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Johnson Pharmacare Ltd.?
Quarterly earnings results and presentations of Johnson Pharmacare Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Johnson Pharmacare Ltd. publish earnings call transcripts?
Earnings call transcripts of Johnson Pharmacare Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Johnson Pharmacare Ltd.?
Investor presentations and annual day presentations of Johnson Pharmacare Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Johnson Pharmacare Ltd.?
Corporate announcements and regulatory filings of Johnson Pharmacare Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Johnson Pharmacare Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Johnson Pharmacare Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Johnson Pharmacare Ltd.?
The ISIN (International Securities Identification Number) of Johnson Pharmacare Ltd. is INE560F01022. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Johnson Pharmacare Ltd. listed?
Johnson Pharmacare Ltd. is listed on NSE and BSE. The NSE symbol is JOHNPHARMA and the BSE code is -.
Where can I find the shareholding pattern of Johnson Pharmacare Ltd.?
The quarterly shareholding pattern of Johnson Pharmacare Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Johnson Pharmacare Ltd. on Sharpely?
Share price data for Johnson Pharmacare Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.